These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28150469)

  • 1. Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds.
    Raposo LR; Roma-Rodrigues C; Jesus J; Martins LMDRS; Pombeiro AJ; Baptista PV; Fernandes AR
    Vet Comp Oncol; 2017 Dec; 15(4):1537-1542. PubMed ID: 28150469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents.
    Fernandes AR; Jesus J; Martins P; Figueiredo S; Rosa D; Martins LM; Corvo ML; Carvalheiro MC; Costa PM; Baptista PV
    J Control Release; 2017 Jan; 245():52-61. PubMed ID: 27871990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.
    Raposo LR; Roma-Rodrigues C; Faísca P; Alves M; Henriques J; Carvalheiro MC; Corvo ML; Baptista PV; Pombeiro AJ; Fernandes AR
    Vet Comp Oncol; 2017 Sep; 15(3):952-967. PubMed ID: 27140424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27.
    Bakirel T; Alkan FÜ; Üstüner O; Çinar S; Yildirim F; Erten G; Bakirel U
    J Vet Med Sci; 2016 May; 78(4):657-68. PubMed ID: 26822118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.
    Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS
    BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer.
    Zambrano-Estrada X; Landaverde-Quiroz B; Dueñas-Bocanegra AA; De Paz-Campos MA; Hernández-Alberto G; Solorio-Perusquia B; Trejo-Mandujano M; Pérez-Guerrero L; Delgado-González E; Anguiano B; Aceves C
    BMC Vet Res; 2018 Mar; 14(1):87. PubMed ID: 29530037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldoxorubicin-loaded nanofibers are cytotoxic for canine mammary carcinoma and osteosarcoma cell lines in vitro: A short communication.
    Stokol T; Wan C; Blakely R; Bellat V; Law B
    Res Vet Sci; 2020 Feb; 128():86-89. PubMed ID: 31760317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
    Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
    J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calotropis procera (Aiton) Dryand (Apocynaceae) as an anti-cancer agent against canine mammary tumor and osteosarcoma cells.
    Rabelo AC; Borghesi J; Carreira ACO; Hayashi RG; Bessa F; Barreto RDSN; da Costa RP; Cantanhede Filho AJ; Carneiro FJC; Miglino MA
    Res Vet Sci; 2021 Sep; 138():79-89. PubMed ID: 34119813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
    Arenas C; Peña L; Granados-Soler JL; Pérez-Alenza MD
    Vet Rec; 2016 Jul; 179(5):125. PubMed ID: 27377395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
    Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
    Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro efficacy of chemotherapeutics as determined by 50% inhibitory concentrations in cell cultures of mammary gland tumors obtained from dogs.
    Simon D; Knebel JW; Baumgartner W; Aufderheide M; Meyer-Lindenberg A; Nolte I
    Am J Vet Res; 2001 Nov; 62(11):1825-30. PubMed ID: 11703031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins downregulate YAP and TAZ and exert anti-cancer effects in canine mammary tumour cells.
    Vigneau AL; Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2022 Jun; 20(2):437-448. PubMed ID: 34881506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factor analysis and clinicopathological characteristics of female dogs with mammary tumours from a single-center retrospective study in Poland.
    Dolka I; Czopowicz M; Stopka D; Wojtkowska A; Kaszak I; Sapierzyński R
    Sci Rep; 2024 Mar; 14(1):5569. PubMed ID: 38448646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer.
    Atmane MI; Vigneau AL; Beaudry F; Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2023 Dec; 21(4):634-645. PubMed ID: 37709554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells.
    Gelaleti GB; Borin TF; Maschio-Signorini LB; Moschetta MG; Hellmén E; Viloria-Petit AM; Zuccari DAPC
    Vet Comp Oncol; 2017 Dec; 15(4):1572-1584. PubMed ID: 28322030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line.
    Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S
    BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the VP3 gene of chicken anemia virus on canine mammary tumor cells.
    Lee JJ; Chen PB; Yang SH; Cheng CH; Chueh LL; Pang VF; Hsiao M; Lin CT
    Am J Vet Res; 2007 Apr; 68(4):411-22. PubMed ID: 17397298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiprogestins mifepristone and onapristone reduce cell proliferation in the canine mammary carcinoma cell line CMT-U27.
    Guil-Luna S; Hellmén E; Sánchez-Céspedes R; Millán Y; Martín de las Mulas J
    Histol Histopathol; 2014 Jul; 29(7):949-55. PubMed ID: 24500783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells.
    Tien YT; Chang MH; Chu PY; Lin CS; Liu CH; Liao AT
    Vet J; 2015 Aug; 205(2):244-53. PubMed ID: 25616642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.